Answers are grounded in this paper and cite their sources.
Vascular aging is a critical factor in cardiovascular diseases. Buyang Huanwu Decoction (BYHWD), a traditional Chinese medicine, shows potential in delaying vascular aging, yet its mechanisms remain unclear. This study aims to explore BYHWD's pharmacological mechanisms through integrative network pharmacology and transcriptomics. Network pharmacology identified BYHWD targets related to aging, followed by pathway enrichment analysis. Vascular histopathology was evaluated using HE, Masson, and EVG staining. Senescence biomarkers SA- β -gal, advanced glycation end products (AGEs), p16, p21, and p53 were determined. Oxidative-inflammatory markers were quantified via ELISA and RT-qPCR. Transcriptomic profiling used Illumina NovaSeq. AMP-activated protein kinase (AMPK) signaling pathway analysis employed immunohistochemistry. Network pharmacology identified 103 key targets, including SIRT1 and AMPK, related to oxidative stress and inflammation. In the D-galactose-induced aging model rats, BYHWD treatment significantly reduced vascular media thickness by 28% in the medium-dose group, collagen deposition, and markers of senescence, such as SA- β -gal, AGEs, p16, p21, and p53. Transcriptomics revealed AMPK signaling pathway enrichment, and further experiments revealed that BYHWD mediates its effects involving activation of the AMPK/Sirt1/Foxo3a axis, a key regulator of vascular homeostasis. BYHWD may attenuate vascular aging by AMPK-mediated regulation of oxidative stress and inflammation, providing a novel multi-target strategy against age-related cardiovascular diseases. The underlying molecular mechanism still needs to be further clarified. Buyang Huanwu Decoction (BYHWD) is a promising traditional Chinese medicinal formulation that introduces an innovative strategy for anti-aging therapy. In the D-galactose-induced aging model rats, BYHWD significantly ameliorated aortic aging phenotypes, with network predictions identifying AMPK signaling pathway as the central hub. Transcriptomics and in vivo validation revealed BYHWD's ability to reactivate AMPK activity, reverse senescence-associated secretory markers, and reduce oxidative stress in aortic tissues. • In aging rats, Buyang Huanwu Decoction (BYHWD) reduces oxidative stress, inflammation, and vascular apoptosis, thereby repairing vascular damage. • Network pharmacology and transcriptomic analysis revealed the AMPK signaling pathway as the key regulator of anti-aging effects. • BYHWD may mitigate vascular aging through AMPK-mediated modulation of oxidative stress and inflammation. • BYHWD may modulate transcription of genes in the AMPK signaling pathway, thereby hindering the aging process.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: